An 80-something patient came in for an annual visit recently and was worried that recent memory lapses might be symptoms of ...

New details have emerged about how Alzheimer’s disease affects the brain. Researchers led by the Allen Institute for Brain Science in Seattle and University of Washington Medicine have ...

Some Diabetes Drugs Tied to Lower Risk of Dementia, Parkinson's Disease Sep. 18, 2024 — A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease ...

Alzheimer's disease may damage the brain in two distinct phases, based on new research funded by the National Institutes of Health (NIH) using sophisticated brain mapping tools. According to ...

Diagnosis of Alzheimer's disease (AD) is currently largely based on the presence of biomarkers. This may lead to a ...

Here Are Other Stocks Moving In Monday's Mid-Day Session Avi Kapoor Neurodegenerative Disease-Focused Anavex Life Sciences' Alzheimer's Candidate Slows Disease Progression By Almost 39% Anavex ...

GlobalData reports that at least five pipeline devices are now in the regulatory approval process across the US and Europe, ...

Find out what AI has already brought to Alzheimer's disease research and most importantly, what it can accomplish in the ...

They discovered that patients who were prescribed semaglutide (the active ingredient in Ozempic and Wegovy) had a "significantly" lower risk of developing Alzheimer’s disease compared to people who ...

Lexeo Therapeutics said Wednesday that it received positive data for its Alzheimer's disease treatment, which suggests that higher doses improved results. The clinical-stage genetic medicine company ...

Today, Prof. Howard Feldman presented revised diagnostic criteria for Alzheimer's disease at the Clinical Trials on Alzheimer's Disease (CTAD) Conference in Madrid on behalf of the International ...